GreenLight Biosciences Net Income vs. Revenue
| GRNAWDelisted Stock | USD 0.02 0 25.00% |
For GreenLight Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of GreenLight Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well GreenLight Biosciences Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between GreenLight Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of GreenLight Biosciences Holdings over time as well as its relative position and ranking within its peers.
GreenLight |
GreenLight Biosciences Revenue vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining GreenLight Biosciences's current stock value. Our valuation model uses many indicators to compare GreenLight Biosciences value to that of its competitors to determine the firm's financial worth. GreenLight Biosciences Holdings is rated # 5 in net income category among its peers. It is rated as one of the top companies in revenue category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value GreenLight Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.GreenLight Revenue vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
GreenLight Biosciences |
| = | (167.06 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
GreenLight Biosciences |
| = | 6.38 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
GreenLight Revenue vs Competition
GreenLight Biosciences Holdings is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 197.31 Million. GreenLight Biosciences holds roughly 6.38 Million in revenue claiming about 3% of equities under Health Care industry.
GreenLight Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in GreenLight Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, GreenLight Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of GreenLight Biosciences' change in net profit over the period of time. It can combine multiple indicators of GreenLight Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid products for human health and agriculture applications. The company was founded in 2008 and is headquartered in Medford, Massachusetts. Greenlight Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 280 people.
GreenLight Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on GreenLight Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of GreenLight Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the GreenLight Biosciences' important profitability drivers and their relationship over time.
Use GreenLight Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GreenLight Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GreenLight Biosciences will appreciate offsetting losses from the drop in the long position's value.GreenLight Biosciences Pair Trading
GreenLight Biosciences Holdings Pair Trading Analysis
The ability to find closely correlated positions to GreenLight Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GreenLight Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GreenLight Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GreenLight Biosciences Holdings to buy it.
The correlation of GreenLight Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GreenLight Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GreenLight Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GreenLight Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your GreenLight Biosciences position
In addition to having GreenLight Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Online Gaming Thematic Idea Now
Online Gaming
Companies that are involved in the building and marketing of online gaming-related products. The Online Gaming theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Online Gaming Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in GreenLight Stock
If you are still planning to invest in GreenLight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GreenLight Biosciences' history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |